• Identify current indications for antepartum fetal surveillance
• Describe antepartum fetal surveillance techniques used to assess fetal wellbeing
ANTEPARTUM FETAL SURVEILLANCE
• When should it start?
• 32 weeks for most at-risk patients (ACOG)
• May start earlier if there are multiple high-risk conditions, and delivery at early gestational age would be considered
• How often should it be done?
• No optimum regimen, BUT
• If indication isn't persistent, testing isn't repeated
• If indication persists, maternal condition is stable, and tests are reassuring… typically repeated weekly
ANTEPARTUM ASSESSMENT: GOALS
• Identify patients at risk for stillbirth
• Reduce risk of fetal demise
• Avoid unnecessary intervention
ANTEPARTUM FETAL SURVEILLANCE: POSSIBLE INDICATIONS

Maternal Medical Conditions
• Hypertensive disorders
• Diabetes mellitus
• Renal disease
• Metabolic disorders
• Systemic lupus erythematosus (SLE)
Pregnancy-related Conditions
WHAT'S A PLACENTA DO?
• Fetal lung
• Kidney
• GI tract
• Skin
• Endocrine organ
UTERINE BLOOD FLOW
• Relies on maternal cardiac output (CO)
• CO = Maternal Heart Rate (MHR) x Stroke Volume (SV)
• Maternal blood volume increases by 30-50% during pregnancy
• At term, approximately 500 mL blood per minute HYPOXEMIA AND THE PLACENTA HYPOXIA AND THE FETUS ANTEPARTUM TESTING: FETAL ASSESSMENT
• Fetal kick counts
• Non-stress test
• Biophysical Profile (BPP)
• Modified BPP
• Contraction Stress Test
• Amniocentesis
• Doppler Ultrasound
FETAL KICK COUNTS
• All patients should perform DAILY kick counts
• For high-risk patients, begin at 26 weeks gestation
• Performed daily at a consistent time
• 10 discrete movements in 2 hours;
• Less than 10 movements? Call provider or L&D for follow-up testing
• Call provider if changes in kick-counts
NON-STRESS TEST (NST)
• Outpatient external fetal monitoring (EFM)
• Minimum of 20 minutes • Spontaneous or induced accelerations of fetal heart rate (FHR)
• 32 weeks gestation and older:
• At least 15 beats per minute (bpm), lasting at least 15 seconds
• Less than 32 weeks gestation:
• At least 10 bpm, lasting at least 10 seconds
• No decelerations • Maximum of 40 minutes NST TECHNIQUE
• Place patient in lateral or semi-fowlers position with tilt
• Apply EFM
• Apply blood pressure cuff and oxygen saturation monitor
• Vital signs assessed and documented
• If reactivity noted, test completed in 20 minutes
• May need extended EFM per licensed provider
NST INTERPRETATION
• Reactive
• 2 or more qualifying accelerations in 20 minute period
• Nonreactive
• Less than 2 accelerations or criteria for accelerations not met in 40 minutes
• Unsatisfactory
• Inadequate quality of tracing
• Decelerations
• Warrant further review VIBROACOUSTIC STIMULATION
• 1-3 second stimulation placed over fetal head
• If no response, may repeat up to 3 times for longer durations, up to 3 seconds.
• 1 minute intervals
• If still non-reactive, follow-up with further testing
• Prior to 30 weeks, response may be single prolonged acceleration
CONTRACTION STRESS TEST (CST)
• Assumes that fetal oxygenation will be affected by uterine activity
• If baby's oxygenation is already compromised, we should see late decelerations
• Requires adequate contraction pattern
• At least 3 contractions
• Lasting at least 40 seconds each
• In a 10 minute period of time
• Contraindicated when labor or vaginal delivery is contraindicated
CST: STIMULATING CONTRACTIONS
• Spontaneous contractions
• Nipple stimulation
• Often successful with quicker results
• Intravenous oxytocin
CST INTERPRETATION
• Negative
• No late decelerations, with contractions meeting criteria
• Positive
• Late decelerations with more than 50% of contractions • Does not require 3 contractions in 10 minutes
• Equivocal/Suspicious
• Late decelerations with less than 50% of contractions
• Equivocal
• FHR decelerations in presence of contractions more frequent than every 2 minutes or lasting longer than 90 seconds
• Unable to adequately monitor or complete test NST VS. CST
• Main advantage of NST is that it doesn't require contractions • NSTs have a higher false negative rate than CSTs 
BIOPHYSICAL PROFILE (BPP)
• Combines results of NST with ultrasound testing
• Ultrasound test that captures a snapshot of fetal health by measuring
• Fetal tone
• Breathing movements
• Gross body movement
• Amniotic fluid volume
• NST BPP SCORING CRITERIA
BPP AND FETAL RESPONSE TO STRESS
• Fetus responds to hypoxemia in a predictable, physiological basis.
• Non-reactive NST
• Loss of fetal breathing movements
• Loss of gross body movements
• Loss of tone
• Fetal death
• This helps us estimate the presence and severity of fetal hypoxemia, based on the BPP
MODIFIED BPP
• Combines NST and assessment of amniotic fluid index (AFI)
• Evaluates long-term uteroplacental function
• Amniotic fluid volume reflects fetal urine production
• AFI more than 5cm considered adequate
• Placental dysfunction
• Fetal blood shunted to brain, heart, adrenals
• Decreased renal perfusion leads to oligohydramnios AFI PROCEDURE
• Imaging of uterus in four quadrants
• Measurement of largest vertical drop pocket of amniotic fluid
• Total of four quadrants added together for total index or volume
• 5 cm or more is considered adequate
• Normal: Reactive NST and AFI > 5cm
• Abnormal: Nonreactive NST and AFI < 5cm
FETAL DOPPLER FLOW STUDIES
• Only indicated for intrauterine growth restriction (IUGR) and severe hypertension -not normal pregnancies!
• Measures pulsatile blood flow of umbilical arteries and other fetal vessels
• Umbilical flow velocity of normally grown fetus high-velocity diastolic flow
• Umbilical flow velocity of IUGR fetus diastolic flow is diminished, absent, or reversed
• Poor diastolic flow = blood flow resistance in the placenta
• Reflects current, up-to-the-minute status of placental blood flow
• Used in conjunction with NSTS or BPPs 
